...
机译:胎儿表达的F5 F5和监管F5 F5变体的亚型特异性临床和预后相关性:CoCAV研究
Department of Medical GeneticsOslo University HospitalOslo Norway;
Department of PathologyOslo University HospitalOslo Norway;
Department of PathologyOslo University HospitalOslo Norway;
Department of PathologyOslo University HospitalOslo Norway;
Department of Breast and Endocrine SurgeryOslo University HospitalOslo Norway;
Department of GeneticsOslo University Hospital RadiumhospitaletOslo Norway;
Department of GeneticsOslo University Hospital RadiumhospitaletOslo Norway;
Department of Medical GeneticsOslo University HospitalOslo Norway;
blood coagulation; breast neoplasms; factor V; single nucleotide polymorphism; survival;
机译:胎儿表达的F5 F5和监管F5 F5变体的亚型特异性临床和预后相关性:CoCAV研究
机译:对人类乳腺癌具有特异性的ARHGEF5 / TIM癌基因的替代转录本的表达和分子表征。
机译:IRF5是乳腺癌中CXCL13表达的新型调节剂,可调节CXCR5(+)B细胞和T细胞向肿瘤条件培养基的运输
机译:使用5-氨基乙酰丙酸,二甲基亚砜(DMSO)和乙二胺四乙酸二钠盐(EDTA)局部应用光动力学疗法治疗人类皮肤肿瘤,
机译:阐明恶性横纹肌瘤发展中SNF5调控的基因表达。
机译:卡波济氏肉瘤相关疱疹病毒ORF56,ORF57,ORF58和ORF59的基因结构和表达
机译:KLF5的表达是乳腺癌患者的无病生存和整体存活的预后因素